Global Home Healthcare Market 2016-2020

2016-05-09
Price :
Published : May-2016
No. of Pages : 66

Home healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians.

The analysts forecast Global Home Healthcare Market to grow at a CAGR of 8.85% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the Global Home Healthcare Market for 2016-2020.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • Europe
  • MEA

The report, Global Home Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Johnson & Johnson
  • Omron Healthcare
  • Philips
  • McKesson
  • Roche Holdings

Other prominent vendors

  • A&D Company
  • Abbott
  • Almost Family
  • Apria Healthcare
  • eCaring
  • Fresenius
  • Gentiva Health Services
  • Interim Healthcare
  • Kindred Healthcare
  • Linde Healthcare
  • LJC Group
  • Kinnser Software
  • Rotech Healthcare

Market driver

  • Growing demand for affordable healthcare solutions
  • For a full, detailed list, view our report

Market challenge

  • Complexity in pricing
  • For a full, detailed list, view our report

Market trend

  • Integration of mobile devices with home healthcare systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : Technavio
More Reports
Title Price Buy Now

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories Summary Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers' busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs. Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription. The pressures of modern life are taking their......
$3450

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides ......
$1000

Asperger Syndrome Global Clinical Trials Review, H1, 2017

Asperger Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Asperger Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Asperger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Asperger Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500

Arterial Calcification Global Clinical Trials Review, H1, 2017

Arterial Calcification Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Calcification. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500

Arterial Stiffness Global Clinical Trials Review, H1, 2017

Arterial Stiffness Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arterial Stiffness Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Arterial Thrombosis Global Clinical Trials Review, H1, 2017

Arterial Thrombosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Arteriosclerosis Global Clinical Trials Review, H1, 2017

Arteriosclerosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H1, 2017" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials databa......
$2500

Arteriovenous Fistula Global Clinical Trials Review, H1, 2017

Arteriovenous Fistula Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2017" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500

Artery Stenosis Global Clinical Trials Review, H1, 2017

Artery Stenosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Artery Stenosis Global Clinical Trials Review, H1, 2017" provides an overview of Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Arthralgia Global Clinical Trials Review, H1, 2017

Arthralgia Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arthralgia Global Clinical Trials Review, H1, 2017" provides an overview of Arthralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500